— Know what they know.
Not Investment Advice

GRDX NASDAQ

GridAI Technologies Corp.
1W: +14.9% 1M: +38.0% 3M: +41.5% YTD: -25.1% 1Y: +203.2% 3Y: -97.7% 5Y: -100.0%
$3.85
+0.07 (+1.85%)
Pre-Market: $3.92 (+0.07, +1.82%)
Weekly Expected Move ±17.6%
$3 $3 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $12.9M mcap · 3M float · 3.94% daily turnover · Short 26% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$12.9M
52W Range1.056-5.84
Volume51,391
Avg Volume116,881
Beta1.39
Dividend
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJason David Sawyer
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2016-10-11
777 Yamato Road
Boca Raton, FL 33431
US
(561) 589-7020
About GridAI Technologies Corp.

GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Recent Insider Trades

NameTypeSharesPriceDate
BORKOWSKI EDWARD A-Award 40,000 2026-01-01
Uppal Manpreet A-Award 40,000 2026-01-01
Pursglove Geordan Ga A-Award 40,000 2026-01-01
Sawyer Jason David A-Award 40,000 2025-12-22
Skowron Anna A-Award 65,000 2025-12-22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms